Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic target for managing metabolic disorders. These naturally occurring substances are secreted by the gut in response to food intake, https://socials360.com/story11022719/unveiling-the-therapeutic-potential-of-glp-1-peptides